Anna Apicella
Impact in
-
- Inflammatory mediators and NSAID effects
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 6
- Cancer Treatment and Pharmacology 2
- Cytokine Signaling Pathways and Interactions 2
-
- Inflammatory mediators and NSAID effects 4
- Co-authors
- Raffaele Zarrilli (6 shared papers)Paolo Ricchi (6 shared papers)Angela M. Acquaviva (6 shared papers)Anna Di Popolo (3 shared papers)Antonella Di Palma (2 shared papers)Sandro Pignata (4 shared papers)Concetta Tuccillo (1 shared paper)Daniel A. Finelli (1 shared paper)
- Journals
- International Journal of Cancer (2 papers)Molecular Pharmacology (1 paper)Clinical & Experimental Immunology (1 paper)Radiology (1 paper)Oncogene (1 paper)
- Partner nations
- ItalyUnited StatesRussia
In The Last Decade
Anna Apicella
16 papers receiving 330 citations
Peers
Comparison fields: 5 of 72
- Pharmacology 77
- Cancer Research 59
- Oncology 86
- Biochemistry 23
- Endocrinology, Diabetes and Metabolism 37
Countries citing papers authored by Anna Apicella
This map shows the geographic impact of Anna Apicella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Apicella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Apicella more than expected).
Fields of papers citing papers by Anna Apicella
This network shows the impact of papers produced by Anna Apicella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Apicella. The network helps show where Anna Apicella may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Apicella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 90 | |
| 2 | 1997 | 56 | |
| 3 | 1999 | 35 | |
| 4 | 2009 | 30 | |
| 5 | 1996 | 25 | |
| 6 | 2003 | 24 | |
| 7 | 2002 | 19 | |
| 8 | 2002 | 19 | |
| 9 | 1999 | 15 | |
| 10 | 1999 | 13 | |
| 11 | 1997 | 7 | |
| 12 | 1998 | 4 | |
| 13 | A new pharmaceutical device containing mesoglycan modulates fibroblasts function in vivo | 2020 | 3 |
| 14 | 1991 | 1 | |
| 15 | 1999 | 1 | |
| 16 | 1997 | 1 |
About Anna Apicella
Anna Apicella is a scholar working on Oncology, Pharmacology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 16 papers that have together received 343 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Medical Imaging Techniques and Applications (2 papers), Cancer Treatment and Pharmacology (2 papers), Estrogen and related hormone effects (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Medical Imaging and Pathology Studies (2 papers). The work is most often cited by research in Pharmacology (77 citations), Cancer Research (59 citations), Oncology (86 citations), Biochemistry (23 citations) and Endocrinology, Diabetes and Metabolism (37 citations). Anna Apicella has collaborated with scholars based in Italy, United States and Russia. Frequent co-authors include Raffaele Zarrilli, Paolo Ricchi, Angela M. Acquaviva, Anna Di Popolo, Antonella Di Palma, Sandro Pignata, Concetta Tuccillo, Daniel A. Finelli, Gregory C. Hurst and Tiziana Di Matola. Their work appears in journals such as International Journal of Cancer, Molecular Pharmacology, Clinical & Experimental Immunology, Radiology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.